161 related articles for article (PubMed ID: 22834926)
1. Time course analysis of Candida albicans metabolites during biofilm development.
Zhu Z; Wang H; Shang Q; Jiang Y; Cao Y; Chai Y
J Proteome Res; 2013 Jun; 12(6):2375-85. PubMed ID: 22834926
[TBL] [Abstract][Full Text] [Related]
2. Effect of amphotericin B on the metabolic profiles of Candida albicans.
Cao Y; Zhu Z; Chen X; Yao X; Zhao L; Wang H; Yan L; Wu H; Chai Y; Jiang Y
J Proteome Res; 2013 Jun; 12(6):2921-32. PubMed ID: 23672250
[TBL] [Abstract][Full Text] [Related]
3. Ion-pairing chromatography on a porous graphitic carbon column coupled with time-of-flight mass spectrometry for targeted and untargeted profiling of amino acid biomarkers involved in Candida albicans biofilm formation.
Chen X; Wu H; Cao Y; Yao X; Zhao L; Wang T; Yang Y; Lv D; Chai Y; Cao Y; Zhu Z
Mol Biosyst; 2014 Jan; 10(1):74-85. PubMed ID: 24150280
[TBL] [Abstract][Full Text] [Related]
4. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
5. A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations.
Bojsen R; Regenberg B; Gresham D; Folkesson A
Sci Rep; 2016 Feb; 6():21874. PubMed ID: 26903175
[TBL] [Abstract][Full Text] [Related]
6. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
7. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
8. In vitro method to study antifungal perfusion in Candida biofilms.
Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
[TBL] [Abstract][Full Text] [Related]
9. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
Braga PC; Culici M; Alfieri M; Dal Sasso M
Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation.
Caldara M; Marmiroli N
Int J Antimicrob Agents; 2018 Oct; 52(4):500-505. PubMed ID: 29990546
[TBL] [Abstract][Full Text] [Related]
11. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures.
Wei GX; Xu X; Wu CD
Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
[TBL] [Abstract][Full Text] [Related]
14. Candida albicans biofilm formation is associated with increased anti-oxidative capacities.
Seneviratne CJ; Wang Y; Jin L; Abiko Y; Samaranayake LP
Proteomics; 2008 Jul; 8(14):2936-47. PubMed ID: 18655069
[TBL] [Abstract][Full Text] [Related]
15. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
De Brucker K; De Cremer K; Cammue BP; Thevissen K
Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
[TBL] [Abstract][Full Text] [Related]
16. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
Khan MS; Ahmad I
J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
[TBL] [Abstract][Full Text] [Related]
17. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Lamfon H; Porter SR; McCullough M; Pratten J
J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans biofilms produce antifungal-tolerant persister cells.
LaFleur MD; Kumamoto CA; Lewis K
Antimicrob Agents Chemother; 2006 Nov; 50(11):3839-46. PubMed ID: 16923951
[TBL] [Abstract][Full Text] [Related]
20. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
